Caseware UK (AP4) 2025.0.111 2025.0.111 2025-08-31 2025-08-31 0 No description of principal activity 2024-09-01 false 0 true true The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 04503546 2024-09-01 2025-08-31 04503546 2023-09-01 2024-08-31 04503546 2025-08-31 04503546 2024-08-31 04503546 2023-09-01 04503546 c:Director1 2024-09-01 2025-08-31 04503546 c:RegisteredOffice 2024-09-01 2025-08-31 04503546 d:CurrentFinancialInstruments 2025-08-31 04503546 d:CurrentFinancialInstruments 2024-08-31 04503546 d:CurrentFinancialInstruments d:WithinOneYear 2025-08-31 04503546 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 04503546 d:ShareCapital 2025-08-31 04503546 d:ShareCapital 2024-08-31 04503546 d:ShareCapital 2023-09-01 04503546 d:RetainedEarningsAccumulatedLosses 2024-09-01 2025-08-31 04503546 d:RetainedEarningsAccumulatedLosses 2025-08-31 04503546 d:RetainedEarningsAccumulatedLosses 2023-09-01 2024-08-31 04503546 d:RetainedEarningsAccumulatedLosses 2024-08-31 04503546 d:RetainedEarningsAccumulatedLosses 2023-09-01 04503546 c:OrdinaryShareClass1 2024-09-01 2025-08-31 04503546 c:OrdinaryShareClass1 2025-08-31 04503546 c:FRS102 2024-09-01 2025-08-31 04503546 c:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 04503546 c:FullAccounts 2024-09-01 2025-08-31 04503546 c:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 04503546 2 2024-09-01 2025-08-31 04503546 e:PoundSterling 2024-09-01 2025-08-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 04503546 NOVEL THEATRE COMPANY LIMITED UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025
NOVEL THEATRE COMPANY LIMITED CONTENTS
| Page
Company information | 1
Balance sheet | 2
Statement of changes in equity | 3
Notes to the financial statements | 4 - 10
NOVEL THEATRE COMPANY LIMITED COMPANY INFORMATION
Director | M N Bentley
Registered number | 04503546
Registered office | 16 Great Queen Street
| Covent Garden
| London
| WC2B 5AH
Accountants | Blick Rothenberg Limited
| Chartered Accountants
| 16 Great Queen Street
| Covent Garden
| London
| WC2B 5AH
Page 1
|  | REGISTERED NUMBER:04503546
NOVEL THEATRE COMPANY LIMITED BALANCE SHEET AS AT 31 AUGUST 2025
|  |  |  | As restated
|  | 2025 |  | 2024
Note |  | £ |  | £
Current assets |  |  |  |  |
Debtors: amounts falling due within one year | 4 | 1,419,296 |  | 611,306 |
Cash at bank and in hand |  | 3,685,861 |  | 3,223,996 |
|  | 5,105,157 |  | 3,835,302 |
Creditors: amounts falling due within one year | 5 | (2,901,881) |  | (2,736,863) |
Net current assets |  |  | 2,203,276 |  | 1,098,439
Net assets |  |  | 2,203,276 |  | 1,098,439
Capital and reserves |  |  |  |  |
Called up share capital | 6 |  | 1 |  | 1
Profit and loss account |  |  | 2,203,275 |  | 1,098,438
Total equity |  |  | 2,203,276 |  | 1,098,439
The director considers that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue and were signed by:
M N Bentley
Director
Date: 23 July 2026
The notes on pages 4 to 10 form part of these financial statements. Page 2
NOVEL THEATRE COMPANY LIMITED STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31 AUGUST 2025
| Called up share capital | Profit and loss account | Total equity
| £ | £ | £
At 1 September 2023 | 1 | 160,271 | 160,272
Profit for the year (as restated) | - | 938,167 | 938,167
At 1 September 2024 (as restated) | 1 | 1,098,438 | 1,098,439
Profit for the year | - | 1,104,837 | 1,104,837
At 31 August 2025 | 1 | 2,203,275 | 2,203,276
Page 3
NOVEL THEATRE COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025
1. | General information
Novel Theatre Company Limited is a private company limited by shares incorporated in England and Wales. The registered office is 16 Great Queen Street, Covent Garden, London, WC2B 5AH. The financial statements are presented in Sterling (£), which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the company's accounting policies. The following principal accounting policies have been applied:
| 2.2 | Going concern
After making enquiries, the director has reasonable expectation that the company has adequate resources to continue in operational existence and meet its liabilities as they fall due for the foreseeable future, being a period of at least twelve months from the date these financial statements were approved. Accordingly, he continues to adopt the going concern basis in preparing the financial statements.
| 2.3 | Prior year adjustment
The company has restated its comparative figures for the year ended 31 August 2024 and it's brought forward profit and loss account reserves as at 1 September 2024. An explanation of the adjustments together with the financial impact is set out in Note 8.
| 2.4 | Turnover
Turnover represents amounts receivable for royalties and production profits net of VAT and trade discounts. Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered. Page 4
NOVEL THEATRE COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025 2.Accounting policies (continued)
| 2.5 | Financial instruments
The company has elected to apply Sections 11 and 12 of FRS 102 in respect of financial instruments. Financial assets and financial liabilities are recognised when the company becomes party to the contractual provisions of the instrument. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. The company’s policies for its major classes of financial assets and financial liabilities are set out below. Financial assets Basic financial assets, including trade and other debtors, and cash and bank balances, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment. Financial liabilities Basic financial liabilities, including trade and other creditors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Impairment of financial assets Financial assets measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the profit and loss account. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between the asset's carrying amount and the best estimate of the amount the company would receive for the asset if it were to be sold at the reporting date. For financial assets measured at amortised cost, the impairment loss is measured as the difference between the asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If the financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss. Page 5
NOVEL THEATRE COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025 2.Accounting policies (continued)
|  | Financial instruments (continued)
Derecognition of financial assets and financial liabilities Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions. Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires. Offsetting of financial assets and financial liabilities Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
| 2.6 | Cash
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.
| 2.7 | Share capital
Ordinary shares are classified as equity.
| 2.8 | Interest income
Interest income is recognised in profit or loss using the effective interest method. Page 6
NOVEL THEATRE COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025 2.Accounting policies (continued)
| 2.9 | Foreign currency translation
Functional and presentation currency The company's functional and presentational currency is £. Transactions and balances Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges. Foreign exchange gains and losses are presented in profit or loss within 'administrative expenses'.
| 2.10 | Current and deferred tax
The tax expense for the year comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. Current tax is the amount of income tax payable in respect of taxable profit for the year or prior years. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income. Deferred tax arises from timing differences that are differences between taxable profits and total comprehensive income as stated in the financial statements. These timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in the financial statements. Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that: ∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and ∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met. Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Page 7
NOVEL THEATRE COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025
3. | Employees
| The average monthly number of employees, including directors, during the year was 0 (2024 - 0).
4. | Debtors
|  |  |  |  |  | As restated
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade debtors | 1,910 | -
| Other debtors | 1,416,853 | 610,436
| Prepayments | 533 | 870
|  | 1,419,296 | 611,306
5. | Creditors: amounts falling due within one year
|  |  |  |  |  | As restated
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade creditors | 7,717 | 9,372
| Corporation tax | 478,467 | 299,342
| Other taxation and social security | - | 20,452
| Other creditors | 2,400,697 | 2,400,697
| Accruals | 15,000 | 7,000
|  | 2,901,881 | 2,736,863
6. | Share capital
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
|  | Allotted, called up and fully paid |  |
|  | 1 Ordinary share of £1.00 | 1 | 1
7. | Directors' transactions
Other creditors of £2,400,697 (2024: £2,400,697) comprise an amount owed to the director. This is interest free and is unsecured. There are no formal terms and conditions regarding its repayment. Page 8
NOVEL THEATRE COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025
8. | Prior year adjustment
In preparing these financial statements, the director identified that amounts advanced to third party theatre productions under co-production funding arrangements had previously been recognised within direct costs. Following a review of the underlying arrangements, it was concluded that these balances should be recognised within other debtors. The prior year adjustment also includes £51,197 of expenditure funded by a director on behalf of the company and recognised within other creditors. Accordingly, the comparative figures for the year ended 31 August 2024 have been restated. The impact of the prior year adjustments and related reclassifications on the comparative balance sheet, equity and profit for the year is shown in the reconciliation tables below.
| Reconciliation of changes to the balance sheet as at 31 August 2024
|  | As previously reported | Adjustment | As restated
|  | £ | £ | £
| Other debtors | 870 | 710,436 | 711,306
| Corporation tax | (159,532) | (139,810) | (299,342)
| Other creditors | (2,349,500) | (51,197) | (2,400,697)
| Reconciliation of changes in equity
|  | 1 September 2023 | 31 August 2024
|  | £ | £
| Equity as previously reported | 160,272 | 679,010
| Adjustments to prior year |  |
| Adjustments to profit and loss account | - | 419,429
| Equity as adjusted | 160,272 | 1,098,439
Page 9
NOVEL THEATRE COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025
| Prior year adjustment (continued)
| Reconciliation of changes in profit for the year ended 31 August 2024
|  | Year ended 31 August 2024
|  | £
| Profit as previously reported | 518,738
| Adjustments to prior year | -
| Turnover | (494,456)
| Cost of sales | 687,461
| Other operating income | 227,883
| Investment income | 138,351
| Corporation tax expense | (139,810)
| Profit as adjusted | 938,167
Page 10